Notch interaction with RUNX factors regulates initiation of the T-lineage program
Journal of Experimental Medicine · 2026
DOI: 10.1084/jem.20250911 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2026. Verfasst von Yuichi Kama und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Tokai University School of Medicine, Isehara, Japan. Hauptthemen laut MEDLINE: T-Lymphocytes, Cell Lineage, CCCTC-Binding Factor, Core Binding Factor Alpha 2 Subunit. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Tokai University, Chugai Foundation for Innovative Drug Discovery Science.
Abstract (Originalsprache)
Runt-related transcription (RUNX) factors play a key role in T cell development. At the T-lineage commitment checkpoint, RUNX1 undergoes dynamic partner switching, resulting in its redeployment. Here, we investigated the functional differences in RUNX factors between the lymphoid progenitor (LP)– and Notch-stimulated earliest T progenitor stages (Phase 1). We identified CCCTC-binding factor (CTCF) as an LP-specific RUNX1-interacting partner, with LP-specific RUNX1-binding genomic sites significantly enriched for CTCF consensus motifs and co-occupied by CTCF. On Notch stimulation, Notch1 intracellular domain directly interacts with RUNX1 and recruits the RUNX1/Mediator/p300 transcriptional activation complex to Notch-regulated T-signature gene loci. CRISPR/Cas9-mediated stage-specific deletion of RUNX factors and their binding partners revealed that the RUNX1/CTCF complex in LP negatively regulates T-signature gene expression, whereas the RUNX1/Mediator/p300 complex in Phase 1 promotes it. Our findings highlight the crucial role of Notch-mediated functional conversion of RUNX factors, including protein complex reorganization and genomic redeployment in initiating T-lineage program.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Tokai University School of Medicine, Isehara, Japan.
- Department of Pharmacology and Regenerative Medicine, University of Illinois at Chicago, Chicago, IL, USA.
- Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Kisarazu, Japan.
- Department of Omics Medicine, Graduate School of Medicine, Chiba University, Chuo-ku, Japan.
- Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chuo-ku, Japan.
- Translational Molecular Therapeutics Laboratory, Division of Host Defense Mechanism, Tokai University School of Medicine, Isehara, Japan.
ORCID-Profile: Yuichi Kama, Ken-Ichi Hirano, Kaori Masuhara, Yusuke Endo, Yuka Suzuki, Masanori Fujimoto, Tatsuma Matsuda, Takashi Yahata, Masahiko Kato, Katsuto Hozumi, Tomoaki Tanaka, Hiroyuki Hosokawa
Förderung
- Japan Society for the Promotion of Science
- Tokai University
- Chugai Foundation for Innovative Drug Discovery Science
- Uehara Memorial Foundation
- Naito Foundation
- Takeda Science Foundation
- SENSHIN Medical Research Foundation
- Princess Takamatsu Cancer Research Fund
Zitieren
APA
Kama, Y., Hirano, K. I., Masuhara, K., Endo, Y., Suzuki, Y., Fujimoto, M., Matsuda, T., Yahata, T., Kato, M., Hozumi, K., Tanaka, T., & Hosokawa, H. (2026). Notch interaction with RUNX factors regulates initiation of the T-lineage program. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20250911
Vancouver
Kama Y, Hirano KI, Masuhara K, Endo Y, Suzuki Y, Fujimoto M, et al. Notch interaction with RUNX factors regulates initiation of the T-lineage program. Journal of Experimental Medicine. 2026. doi:10.1084/jem.20250911
BibTeX
@article{Kama2026,
author = {Kama, Yuichi and Hirano, Ken-Ichi and Masuhara, Kaori and Endo, Yusuke and Suzuki, Yuka and Fujimoto, Masanori and Matsuda, Tatsuma and Yahata, Takashi and Kato, Masahiko and Hozumi, Katsuto and Tanaka, Tomoaki and Hosokawa, Hiroyuki},
title = {Notch interaction with RUNX factors regulates initiation of the T-lineage program},
journal = {Journal of Experimental Medicine},
year = {2026},
doi = {10.1084/jem.20250911}
}
EUVIMED